Search research articles
Contact Us
Filters
Showing results (21-30 of 28) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 28 results.
Scientific Reports
|
August 8, 2020
Geospatial epidemiology of Staphylococcus aureus in a tropical setting: an enabling digital surveillance platform
T M Wozniak, W Cuningham, S Buchanan, et al.
Vaccine
|
June 19, 2022
A quality improvement study: Optimizing pneumococcal vaccination rates in children with cochlear implants
S Tay, A C Bowen, C C Blyth, et al.
Vaccine
|
April 9, 2018
Effectiveness of a 3 + 0 pneumococcal conjugate vaccine schedule against invasive pneumococcal disease among a birth cohort of 1.4 million children in Australia
H F Gidding, L McCallum, P Fathima, et al.
Internal Medicine Journal
|
April 11, 2016
Australasian Society of Infectious Diseases updated guidelines for the management of Clostridium difficile infection in adults and children in Australia and New Zealand
J A Trubiano, A C Cheng, T M Korman, et al.
International Journal of Population Data Science
|
September 16, 2020
Probabilistic linkage of national immunisation and state-based health records for a cohort of 1.9 million births to evaluate Australia's childhood immunisation program
H F Gidding, L McCallum, P Fathima, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
August 27, 2010
The impact of the pandemic influenza A(H1N1) 2009 virus on seasonal influenza A viruses in the southern hemisphere, 2009
C C Blyth, A Kelso, K A McPhie, et al.
The Journal of Infection
|
September 28, 2024
The Platform Trial In COVID-19 Priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity, and safety of different COVID-19 vaccinations administered as a second booster (fourth dose) in AZD1222 primed individuals aged 50-<70 years old
C McLeod, M Dymock, K L Flanagan, et al.
The Journal of Infection
|
November 16, 2024
The Platform Trial In COVID-19 priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity, and safety of licensed COVID-19 vaccinations administered as a second booster in BNT162b2 primed individuals aged 18-<50 and 50-<70 years old
C McLeod, M Dymock, K L Flanagan, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 28) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 28 results.
Scientific Reports
|
August 8, 2020
Geospatial epidemiology of Staphylococcus aureus in a tropical setting: an enabling digital surveillance platform
T M Wozniak, W Cuningham, S Buchanan, et al.
Vaccine
|
June 19, 2022
A quality improvement study: Optimizing pneumococcal vaccination rates in children with cochlear implants
S Tay, A C Bowen, C C Blyth, et al.
Vaccine
|
April 9, 2018
Effectiveness of a 3 + 0 pneumococcal conjugate vaccine schedule against invasive pneumococcal disease among a birth cohort of 1.4 million children in Australia
H F Gidding, L McCallum, P Fathima, et al.
Internal Medicine Journal
|
April 11, 2016
Australasian Society of Infectious Diseases updated guidelines for the management of Clostridium difficile infection in adults and children in Australia and New Zealand
J A Trubiano, A C Cheng, T M Korman, et al.
International Journal of Population Data Science
|
September 16, 2020
Probabilistic linkage of national immunisation and state-based health records for a cohort of 1.9 million births to evaluate Australia's childhood immunisation program
H F Gidding, L McCallum, P Fathima, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
August 27, 2010
The impact of the pandemic influenza A(H1N1) 2009 virus on seasonal influenza A viruses in the southern hemisphere, 2009
C C Blyth, A Kelso, K A McPhie, et al.
The Journal of Infection
|
September 28, 2024
The Platform Trial In COVID-19 Priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity, and safety of different COVID-19 vaccinations administered as a second booster (fourth dose) in AZD1222 primed individuals aged 50-<70 years old
C McLeod, M Dymock, K L Flanagan, et al.
The Journal of Infection
|
November 16, 2024
The Platform Trial In COVID-19 priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity, and safety of licensed COVID-19 vaccinations administered as a second booster in BNT162b2 primed individuals aged 18-<50 and 50-<70 years old
C McLeod, M Dymock, K L Flanagan, et al.
Page
of 3